What makes ALOXI different?
ALOXI® is an antinausea
medication known as a 5-HT3 receptor antagonist that prevents chemotherapy-induced nausea and vomiting (CINV) after certain
chemotherapies. It works by blocking the antinausea signal to the brain. With some
5-HT3 drugs, patients need to take multiple doses after chemotherapy
to help prevent nausea and vomiting. Not so with ALOXI.
Just one dose of ALOXI may help prevent nausea and vomiting caused by chemotherapy.
A single IV dose before treatment can give you up to 5 days of strength against
certain types of CINV.
This means you may not need to take any additional oral medications for nausea on
the days following chemotherapy.
For certain types of chemotherapy, ALOXI effectively controls:
- Acute CINV: occurs on the same day as chemotherapy treatment, especially
within the first 24 hours
- Delayed CINV: occurs on the days following chemotherapy, usually within 24
to 72 hours